<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-viruses-12-00339">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Weibel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Raab</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Y.A.</given-names>
   </name>
   <name>
    <surname>Worschech</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Marincola</surname>
    <given-names>F.M.</given-names>
   </name>
   <name>
    <surname>Szalay</surname>
    <given-names>A.A.</given-names>
   </name>
  </person-group>
  <article-title>Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection</article-title>
  <source>BMC Cancer</source>
  <year>2011</year>
  <volume>11</volume>
  <elocation-id>68</elocation-id>
  <pub-id pub-id-type="doi">10.1186/1471-2407-11-68</pub-id>
  <?supplied-pmid 21320309?>
  <pub-id pub-id-type="pmid">21320309</pub-id>
 </element-citation>
</ref>
